US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acurx Pharmaceuticals, LLC*

0.3800

+0.01102.98%

Volume:38.95K

Turnover:14.68K

Market Cap:8.38M

PE:-0.44

High:0.3800

Open:0.3700

Low:0.3700

Close:0.3690

Loading ...

Overview Company News Filings

Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors

New to The Street Renews Acurx Pharmaceuticals (NASDAQ: ACXP) for Exclusive 6-Month Media Series Including Nationwide TV, Earned Media, and Expanded Digital Reach

ACCESS Newswire

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President Tyler Korman - as Sponsored Programming

ACCESS Newswire

Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know

Acurx price target lowered to $5 from $14 at Alliance Global Partners

Acurx Pharmaceuticals FY 2024 GAAP EPS $(0.87) Beats $(1.52) Estimate

Acurx Pharmaceuticals Q4 Net Income USD -2.8 Million

THOMSON REUTERS

Acurx Pharmaceuticals Inc: Qtrly Net Loss of $0.16 per Share

THOMSON REUTERS

Acurx Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview

Acurx Pharmaceuticals, Inc. Announces Closing of $1.1 Million Registered Direct Offering

THOMSON REUTERS

Acurx Pharmaceuticals, Inc. Announces Closing of $1.1 Million Registered Direct Offering

Dow Dips Over 250 Points; Genesco Shares Plunge After Q4 Results

Acurx Pharmaceuticals Launches $1.1 Million Registered Direct Offering; Shares Fall

MT Newswires Live

BRIEF-Acurx Pharmaceuticals Announces $1.1 Million Registered Direct Offering

Acurx to sell 2.745M shares at 40c in registered direct offering

Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering

THOMSON REUTERS

Acurx Announces Publication of Nonclinical in Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects From Other Anti-Cdi Antibiotics

THOMSON REUTERS

Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics

Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ACXP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACXP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACXP\",,,,,undefined,":{"symbol":"ACXP","market":"US","secType":"STK","nameCN":"Acurx Pharmaceuticals, LLC*","latestPrice":0.38,"timestamp":1745338812713,"preClose":0.369,"halted":0,"volume":38945,"delay":0,"floatShares":19785381,"shares":22042511,"eps":-0.872535,"marketStatus":"Trading","change":0.011,"latestTime":"04-22 12:33:42 EDT","open":0.37,"high":0.38,"low":0.37,"amount":14682.847617200001,"amplitude":0.0271,"askPrice":0.38,"askSize":400,"bidPrice":0.3795,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.872535,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":0.369,"postHourTrading":{"tag":"盘后","latestPrice":0.35,"preClose":0.369,"latestTime":"19:05 EDT","volume":6960,"amount":2507.842,"timestamp":1745276704192},"volumeRatio":0.710428,"impliedVol":0.3163,"impliedVolPercentile":0.092},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACXP\",,,,,undefined,":{"symbol":"ACXP","floatShares":19785381,"roa":"-152.41%","roe":"-534.03%","lyrEps":-0.872535,"volumeRatio":0.710428,"shares":22042511,"dividePrice":0,"high":0.38,"amplitude":0.0271,"preClose":0.369,"low":0.37,"week52Low":0.3,"pbRate":"13.62","week52High":3.325,"institutionHeld":0,"latestPrice":0.38,"committee":-0.6,"eps":-0.872535,"divideRate":0,"volume":38945,"delay":0,"ttmEps":-0.872535,"open":0.37,"prevYearClose":0.814,"prevWeekClose":0.3728,"prevMonthClose":0.39,"prevQuarterClose":0.39,"fiveDayClose":0.3824,"twentyDayClose":0.4309,"sixtyDayClose":0.8716},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACXP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528971583","title":"Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2528971583","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528971583?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:30","pubTimestamp":1744889400,"startTime":"0","endTime":"0","summary":"About Acurx Pharmaceuticals, Inc.Acurx Pharmaceuticals is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. The Company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum  that blocks the active site of the Gram-positive specific bacterial enzyme DNA polymerase IIIC , inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin- resistant Staphylococcus aureus , vancomycin resistant Enterococcus , drug- resistant Streptococcus pneumoniae  and B. anthracis . Acurx's lead product candidate, ibezapolstat, for the treatment of C. difficile Infection is Phase 3 ready with plans in progress to begin international clinical trials as soon as possible. The Company's preclinical pipeline includes development o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/indian-patent-office-grants-acurx-113000595.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/indian-patent-office-grants-acurx-113000595.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACXP","BK4109","BK4563","DNA","BK4194","BK4139","BK4539","VRE"],"gpt_icon":0},{"id":"2528227482","title":"New to The Street Renews Acurx Pharmaceuticals (NASDAQ: ACXP) for Exclusive 6-Month Media Series Including Nationwide TV, Earned Media, and Expanded Digital Reach","url":"https://stock-news.laohu8.com/highlight/detail?id=2528227482","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528227482?lang=en_us&edition=fundamental","pubTime":"2025-04-17 00:45","pubTimestamp":1744821900,"startTime":"0","endTime":"0","summary":"NEW YORK CITY, NEW YORK / ACCESS Newswire / April 16, 2025 / New to The Street, a premier business television and media platform, is proud to announce the renewal of its media partnership with Acurx Pharmaceuticals, Inc.  for a new 6-month strategic campaign. The series will include long-form interviews airing as sponsored programming on Fox Business and Bloomberg Television, earned media placements, over 50 national commercials per month, and expanded visibility across New to The Street's 2.4M+ subscriber YouTube channel and digital networks.As a late-stage biopharmaceutical company pioneering a new class of antibiotics to combat drug-resistant infections, Acurx Pharmaceuticals continues to make headlines with its scientific breakthroughs and clinical developments. This renewed campaign will enhance Acurx's visibility among investors, healthcare professionals, and the broader biotech community.\"We're excited to expand our media footprint with New to The Street,\" said David P. Luci, Pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/street-renews-acurx-pharmaceuticals-nasdaq-164500720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2095319765.USD","BK4139","BK4563","LU2210149790.SGD","BK4539","NDAQ","IE00B64PRP62.GBP","ACXP","BK4112","BK4100","IE00B3QW5Z07.USD","IE00BKPKM429.USD","TV","IE00BGHQF748.EUR","LU2210150020.SGD",".IXIC","BK4585","BK4588"],"gpt_icon":0},{"id":"2526615407","title":"New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's  Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President Tyler Korman - as Sponsored Programming","url":"https://stock-news.laohu8.com/highlight/detail?id=2526615407","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526615407?lang=en_us&edition=fundamental","pubTime":"2025-04-12 00:45","pubTimestamp":1744389900,"startTime":"0","endTime":"0","summary":"New Segment \"Market Bites\" Debuts with Chef John Doherty of BlackBarn Showcasing the Culinary Side of Business Leadership. NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / New to The Street, a leading financial media TV series, is excited to announce its Bloomberg Television broadcast this Saturday, April 12 at 6:30 PM ET, airing as sponsored programming. This week's episode features a dynamic group of innovators and executives transforming industries across healthcare, biotech, sustainability, and enzyme technology - with a special culinary segment connecting business and lifestyle.Segment Debut: \"Market Bites\"This week also marks the premiere of New to The Street's new culinary lifestyle segment, \"Market Bites,\" spotlighting renowned chefs who are also savvy entrepreneurs. In this debut, Chef John Doherty, the visionary behind BlackBarn in Manhattan, takes viewers inside his kitchen and mindset - blending flavor with business strategy in an inspiring interview filmed on l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/street-announces-bloomberg-television-lineup-164500675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","USAW.SI","BK4561","TQQQ","QID","BK4144","BK4563","TYL","LU0390134368.USD","TISI","BK4023","BK4588","USJW.SI","SQQQ","ACXP","BK4539","BK4585","NQmain","BK4581","RDZN","ET","NVIW.SI","MNQmain",".IXIC","QLD","BK4139","BK4590","BK4120","BIVI","SGTM","RDZNW","TSYW.SI"],"gpt_icon":1},{"id":"2525110812","title":"Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2525110812","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525110812?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:55","pubTimestamp":1744120504,"startTime":"0","endTime":"0","summary":"Shares of Acurx Pharmaceuticals, Inc.  have been struggling lately and have lost 15.9% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road.The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor that makes a bullish case for the stock. On the fundamental side, strong agreement among Wall Street analysts in raising earnings estimates for this company enhances its prospects of a trend reversal.What is a Hammer Chart and How to Trade It?If this is not enough, you should note that ACXP currently has a Zacks Rank #2 , which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-acxp-may-bottom-135504915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACXP","BK4539","BK4139","BK4563"],"gpt_icon":0},{"id":"2521253768","title":"Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2521253768","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521253768?lang=en_us&edition=fundamental","pubTime":"2025-03-22 00:00","pubTimestamp":1742572808,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals, Inc.  could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 . This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.Therefore, the Zacks rating upgrade for Acurx Pharmaceuticals basically reflects positivity about its earnings outlook that could translate into buying pressure and an ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-acxp-upgraded-buy-160008145.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACXP"],"gpt_icon":0},{"id":"2520981360","title":"Acurx price target lowered to $5 from $14 at Alliance Global Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2520981360","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520981360?lang=en_us&edition=fundamental","pubTime":"2025-03-19 00:50","pubTimestamp":1742316618,"startTime":"0","endTime":"0","summary":"Alliance Global Partners lowered the firm’s price target on Acurx (ACXP) to $5 from $14 and keeps a Buy rating on the shares after the company repo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acurx-price-target-lowered-to-5-from-14-at-alliance-global-partners?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acurx-price-target-lowered-to-5-from-14-at-alliance-global-partners?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","ACXP","BK4139","BK4539"],"gpt_icon":0},{"id":"2520623774","title":"Acurx Pharmaceuticals FY 2024 GAAP EPS $(0.87) Beats $(1.52) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2520623774","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520623774?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:08","pubTimestamp":1742296102,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.87) per share which beat the analyst consensus estimate of $(1.52) by 42.76 percent. This is a 24.35 percent increase over losses of $(1.15) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44373161/acurx-pharmaceuticals-fy-2024-gaap-eps-0-87-beats-1-52-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Acurx Pharmaceuticals FY 2024 GAAP EPS $(0.87) Beats $(1.52) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP"],"gpt_icon":0},{"id":"2520623550","title":"Acurx Pharmaceuticals Q4 Net Income USD -2.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2520623550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520623550?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:01","pubTimestamp":1742295662,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nPLX5417DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","ACXP","BK4139","BK4539"],"gpt_icon":0},{"id":"2520454623","title":"Acurx Pharmaceuticals Inc: Qtrly Net Loss of $0.16 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2520454623","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520454623?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:01","pubTimestamp":1742295662,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nPLX5417DE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4539","ACXP","BK4139"],"gpt_icon":0},{"id":"2519804147","title":"Acurx Pharmaceuticals Inc  expected to post a loss of 18 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2519804147","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519804147?lang=en_us&edition=fundamental","pubTime":"2025-03-14 21:22","pubTimestamp":1741958528,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc  expected to post a loss of18cents a share - Earnings Preview Acurx Pharmaceuticals Inc ACXP.OQ ACXP.O is expected to report results on March 18 for the period ending Decembe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nL8N3PX19Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP"],"gpt_icon":0},{"id":"2518788401","title":"Acurx Pharmaceuticals, Inc. Announces Closing of $1.1 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2518788401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518788401?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:30","pubTimestamp":1741638604,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nTUA2MKGMN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ACXP","BK4139","BK4563"],"gpt_icon":0},{"id":"2518869857","title":"Acurx Pharmaceuticals, Inc. Announces Closing of $1.1 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2518869857","media":"PR Newswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518869857?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:30","pubTimestamp":1741638600,"startTime":"0","endTime":"0","summary":"STATEN ISLAND, N.Y., March 10, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc.  , a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced the closing of its previously announced registered direct offering of 2,745,000 shares of its common stock  at a purchase price of $0.40 per share . In addition, in a concurrent private placement, the Company issued unregistered short-term warrants to purchase up to 8,235,000 shares of common stock. The warrants have an exercise price of $0.40 per share, will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares of common stock upon exercise of the warrants  and will expire twenty-four months following the date of Stockholder Approval.H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-inc-announces-closing-203000492.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-inc-announces-closing-203000492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4563","BK4194","ACXP","VRE","BK4539"],"gpt_icon":0},{"id":"2517552314","title":"Dow Dips Over 250 Points; Genesco Shares Plunge After Q4 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2517552314","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517552314?lang=en_us&edition=fundamental","pubTime":"2025-03-08 01:29","pubTimestamp":1741368558,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44197782/dow-dips-over-250-points-genesco-shares-plunge-after-q4-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4094","APEI","BK4122","BK4139","PSQ","TSYW.SI","BK4587","QID","BK4096","QLD","BK4123","WLDN","GCO","ACXP","BK4204","USAW.SI","SUNE","NQmain","TQQQ","MNQmain","NVIW.SI","PCOM","BK4563","BK4134","USJW.SI","SQQQ",".IXIC","BK4539"],"gpt_icon":1},{"id":"2517431071","title":"Acurx Pharmaceuticals Launches $1.1 Million Registered Direct Offering; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2517431071","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517431071?lang=en_us&edition=fundamental","pubTime":"2025-03-07 23:06","pubTimestamp":1741359972,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals  said Friday it will sell 2.7 million shares at $0.40 per share in a registered direct offering to raise gross proceeds of $1.1 million.The late-stage biopharmaceutical company said it will also issue warrants in a concurrent private placement to purchase up to 8.2 million shares, exercisable at $0.40 per share.Net proceeds will be used for working capital and other general corporate purposes, the company said. The offering is expected to close on or about Monday.Acurx shares were down 28% in recent trading.Price: 0.49, Change: -0.16, Percent Change: -24.69","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4563","ACXP","BK4139","BK4539"],"gpt_icon":0},{"id":"2517252480","title":"BRIEF-Acurx Pharmaceuticals Announces $1.1 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2517252480","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517252480?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:14","pubTimestamp":1741353260,"startTime":"0","endTime":"0","summary":"BRIEF-Acurx Pharmaceuticals Announces $1.1 Million Registered Direct OfferingMarch 7 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O:ACURX PHARMACEUTICALS, INC. ANNOUNCES $1.1 MILLION REGISTERED DIRECT O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nTUA9XQHJK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP","BK4539","BK4139","BK4563"],"gpt_icon":0},{"id":"2517480073","title":"Acurx to sell 2.745M shares at 40c in registered direct offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2517480073","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517480073?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:06","pubTimestamp":1741352773,"startTime":"0","endTime":"0","summary":"Acurx (ACXP) Pharmaceuticals announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2.745M shares o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acurx-to-sell-2-745m-shares-at-40c-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acurx-to-sell-2-745m-shares-at-40c-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","ACXP","BK4563"],"gpt_icon":0},{"id":"2517487251","title":"Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2517487251","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517487251?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:00","pubTimestamp":1741352410,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nTUA9XQHJK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4539","BK4139","ACXP"],"gpt_icon":0},{"id":"2516633675","title":"Acurx Announces Publication of Nonclinical in Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects From Other Anti-Cdi Antibiotics","url":"https://stock-news.laohu8.com/highlight/detail?id=2516633675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516633675?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006829,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA7NS76Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACXP","BK4539","BK4139","BK4563"],"gpt_icon":0},{"id":"2516635992","title":"Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics","url":"https://stock-news.laohu8.com/highlight/detail?id=2516635992","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516635992?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006800,"startTime":"0","endTime":"0","summary":"First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat  to other anti-CDI antibiotics in a germ-free mouse model. Changes in alpha and beta microbiome diversities following IBZ treatment were less pronounced compared to those observed in vancomycin -or metronidazole -treated groups, complementing prior Phase 2 clinical findings showing IBZ's more selective antibacterial activity. Notable differences were observed between the microbiome of IBZ- and fidaxomicin -treated groups, which may allow for differentiation of these two anti-CDI antibiotics in future studies. Results establish IBZ differentiating effects on the gut microbiome, indicating a more selective spectrum of microbiome alteration compared to broader-spectrum antibiotics like VAN and MET and a narrower spectrum of microbiome alteration compared to FDX. Preparation continues to advance IBZ into international Ph3 clinical trials for treatment of CDI. IBZ has previously been granted FDA QIDP a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-announces-publication-nonclinical-vivo-130000861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4218","LU0128525689.USD","BK4202","MET","FDX","LU1291159041.SGD","LU0251131958.USD","LU0052756011.USD","BK4563","BK4539","LU1496350502.SGD","LU0048573561.USD","BK4585","NCI","VRE","BK4588","IDSA","BK4135","LU1571399168.USD","LU1267930227.SGD","BK4139","LU0251142724.SGD","PK","LU1989772840.SGD","BK4215","LU1989772923.USD","ECC","LU1989771016.USD","BK4162","BK4533","GAIN","BK4194","LU0742534661.SGD","MAA","ACXP","LU0310800965.SGD","BK4181","BK4131"],"gpt_icon":0},{"id":"2514321656","title":"Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514321656","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514321656?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:00","pubTimestamp":1740747600,"startTime":"0","endTime":"0","summary":"David P. Luci, President and Chief Executive Officer, and Robert G. Shawah, Chief Financial Officer, will host a conference call to discuss the results and provide a business update as follows:. Click here for participant international Toll-Free access numbers. Acurx previously announced that it had received positive regulatory guidance from the EMA during its Scientific Advice Procedure which confirmed that the clinical, non-clinical and CMC  information package submitted to EMA supports advancement of the ibezapolstat Phase 3 program and if the Phase 3 program is successful, supports the submission of a Marketing Authorization Application  for regulatory approval in Europe. The information package submitted to EMA by the Company to which agreement has been reached with EMA included details on Acurx's two planned international Phase 3 clinical trials, 1:1 randomized , primary and secondary endpoints, sample size, statistical analysis plan and the overall registration safety database. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-discuss-fourth-quarter-130000228.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-discuss-fourth-quarter-130000228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACXP","MAA","BK4563","GAIN","BK4585","BK4194","BK4588","BK4139","BK4539","BK4135","BK4215","VRE"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":66,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACXP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-18","symbol":"ACXP","fiscalQuarterEnding":"2024/12","expectedEps":-0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-0.38},{"date":"2024-11-13","symbol":"ACXP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/09","expectedEps":-0.23,"defaultRemindTime":1731488400000,"name":null,"time":"Pre-Market","dateTimestamp":1731474000000,"actualEps":null},{"market":"US","date":"2024-08-09","symbol":"ACXP","fiscalQuarterEnding":"2024/06","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"pre","actualEps":-0.26},{"date":"2024-05-15","symbol":"ACXP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/03","expectedEps":-0.24,"defaultRemindTime":1715760000000,"name":null,"time":"Pre-Market","dateTimestamp":1715745600000,"actualEps":null},{"date":"2024-03-18","symbol":"ACXP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2023/12","expectedEps":-0.26,"defaultRemindTime":1710748800000,"name":null,"time":"Pre-Market","dateTimestamp":1710734400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACXP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACXP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1742529600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACXP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACXP","date":"2025-04-17","current":-0.601894,"percent":0.978678,"low":-15.698763,"twenty":-4.044905,"median":-2.944364,"eighty":-1.932404,"high":-0.462605,"avg":-3.348355,"sd":2.25483,"marketCap":8488570},"quantilePoints":[{"date":"2021-06-11","current":-11.938223,"twenty":-11.938223,"median":-11.938223,"eighty":-11.938223,"marketCap":57246954},{"date":"2021-06-15","current":-11.938223,"twenty":-11.938223,"median":-11.938223,"eighty":-11.938223,"marketCap":57246954},{"date":"2021-06-25","current":-15.698763,"twenty":-11.938223,"median":-11.938223,"eighty":-11.938223,"marketCap":75279744},{"date":"2021-07-02","current":-12.09725,"twenty":-12.878918,"median":-11.938223,"eighty":-11.938223,"marketCap":58009530},{"date":"2021-07-09","current":-12.572868,"twenty":-12.738301,"median":-11.938223,"eighty":-11.938223,"marketCap":60290246},{"date":"2021-07-16","current":-12.469473,"twenty":-12.639041,"median":-12.076571,"eighty":-11.938223,"marketCap":59794438},{"date":"2021-07-23","current":-11.518236,"twenty":-12.560461,"median":-12.014533,"eighty":-11.866925,"marketCap":55233005},{"date":"2021-07-30","current":-11.745706,"twenty":-12.502559,"median":-11.938223,"eighty":-11.580273,"marketCap":56323783},{"date":"2021-08-06","current":-10.050023,"twenty":-12.458729,"median":-11.938223,"eighty":-11.427248,"marketCap":48192532},{"date":"2021-08-13","current":-6.159321,"twenty":-12.399613,"median":-11.893662,"eighty":-10.608357,"marketCap":48572198},{"date":"2021-08-20","current":-5.607549,"twenty":-12.287497,"median":-11.828422,"eighty":-10.06243,"marketCap":44220938},{"date":"2021-08-27","current":-6.172153,"twenty":-12.088978,"median":-11.528575,"eighty":-7.064488,"marketCap":48673390},{"date":"2021-09-03","current":-7.416849,"twenty":-12.051755,"median":-11.476878,"eighty":-6.405694,"marketCap":58489022},{"date":"2021-09-10","current":-6.41596,"twenty":-12.035212,"median":-10.897864,"eighty":-6.364632,"marketCap":50596040},{"date":"2021-09-17","current":-5.877019,"twenty":-12.014533,"median":-10.608357,"eighty":-6.364632,"marketCap":46345972},{"date":"2021-09-24","current":-5.626797,"twenty":-11.938223,"median":-10.215455,"eighty":-6.172153,"marketCap":44372727},{"date":"2021-10-01","current":-6.68543,"twenty":-11.938223,"median":-9.998325,"eighty":-6.159321,"marketCap":52721073},{"date":"2021-10-08","current":-5.248255,"twenty":-11.938223,"median":-9.863911,"eighty":-5.992506,"marketCap":41387560},{"date":"2021-10-15","current":-6.300472,"twenty":-11.938223,"median":-7.333442,"eighty":-5.979674,"marketCap":49685311},{"date":"2021-10-22","current":-6.184985,"twenty":-11.938223,"median":-6.865077,"eighty":-5.979674,"marketCap":48774582},{"date":"2021-10-29","current":-6.41596,"twenty":-11.938223,"median":-6.794501,"eighty":-5.992506,"marketCap":50596040},{"date":"2021-11-05","current":-6.852245,"twenty":-11.938223,"median":-6.865077,"eighty":-6.031002,"marketCap":54036570},{"date":"2021-11-12","current":-4.527743,"twenty":-11.849101,"median":-6.858661,"eighty":-6.031002,"marketCap":50772486},{"date":"2021-11-19","current":-4.427531,"twenty":-11.828422,"median":-6.736758,"eighty":-5.966842,"marketCap":49648749},{"date":"2021-11-26","current":-4.454861,"twenty":-11.828422,"median":-6.68543,"eighty":-5.861621,"marketCap":49955222},{"date":"2021-12-03","current":-3.780711,"twenty":-11.762249,"median":-6.614854,"eighty":-5.699938,"marketCap":42395536},{"date":"2021-12-10","current":-3.835372,"twenty":-11.580273,"median":-6.557111,"eighty":-5.569053,"marketCap":43008484},{"date":"2021-12-17","current":-4.035795,"twenty":-11.522372,"median":-6.505783,"eighty":-5.166131,"marketCap":45255958},{"date":"2021-12-23","current":-4.32732,"twenty":-11.493421,"median":-6.428792,"eighty":-4.527743,"marketCap":48525012},{"date":"2021-12-31","current":-3.936859,"twenty":-11.476878,"median":-6.41596,"eighty":-4.409311,"marketCap":44146523},{"date":"2022-01-07","current":-4.017574,"twenty":-11.439656,"median":-6.358216,"eighty":-4.32732,"marketCap":45051642},{"date":"2022-01-14","current":-4.172447,"twenty":-11.104655,"median":-6.313304,"eighty":-4.289057,"marketCap":46788327},{"date":"2022-01-21","current":-3.316093,"twenty":-10.839963,"median":-6.223481,"eighty":-4.21982,"marketCap":37185482},{"date":"2022-01-28","current":-3.534737,"twenty":-10.695209,"median":-6.172153,"eighty":-4.137828,"marketCap":39637272},{"date":"2022-02-04","current":-3.589398,"twenty":-10.608357,"median":-6.159321,"eighty":-4.074057,"marketCap":40250220},{"date":"2022-02-11","current":-3.71694,"twenty":-10.550456,"median":-6.063082,"eighty":-4.024862,"marketCap":41680431},{"date":"2022-02-18","current":-3.73516,"twenty":-10.364344,"median":-5.979674,"eighty":-3.984778,"marketCap":41884747},{"date":"2022-02-25","current":-3.252322,"twenty":-10.194776,"median":-5.966842,"eighty":-3.953804,"marketCap":36470377},{"date":"2022-03-04","current":-3.252322,"twenty":-10.099653,"median":-5.896267,"eighty":-3.859058,"marketCap":36470377},{"date":"2022-03-11","current":-3.644059,"twenty":-10.029344,"median":-5.787196,"eighty":-3.791643,"marketCap":40863168},{"date":"2022-03-18","current":-2.922007,"twenty":-9.942491,"median":-5.68454,"eighty":-3.755202,"marketCap":37248855},{"date":"2022-03-25","current":-2.838922,"twenty":-9.913541,"median":-5.607549,"eighty":-3.720584,"marketCap":36189718},{"date":"2022-04-01","current":-2.737374,"twenty":-9.379631,"median":-5.44715,"eighty":-3.682321,"marketCap":34895218},{"date":"2022-04-08","current":-2.881869,"twenty":-7.43738,"median":-5.248255,"eighty":-3.645881,"marketCap":36737195},{"date":"2022-04-14","current":-3.210996,"twenty":-7.416849,"median":-4.609734,"eighty":-3.634948,"marketCap":40932808},{"date":"2022-04-22","current":-3.210996,"twenty":-7.250034,"median":-4.504968,"eighty":-3.534737,"marketCap":40932808},{"date":"2022-04-29","current":-3.003032,"twenty":-7.237203,"median":-4.427531,"eighty":-3.388974,"marketCap":38281743},{"date":"2022-05-06","current":-3.123797,"twenty":-7.121715,"median":-4.35465,"eighty":-3.315273,"marketCap":39821223},{"date":"2022-05-13","current":-1.994712,"twenty":-7.044724,"median":-4.32732,"eighty":-3.252322,"marketCap":27813277},{"date":"2022-05-20","current":-1.943188,"twenty":-7.01906,"median":-4.318209,"eighty":-3.210996,"marketCap":27094853},{"date":"2022-05-27","current":-1.923388,"twenty":-6.993396,"median":-4.236218,"eighty":-3.146776,"marketCap":26818773},{"date":"2022-06-03","current":-1.880623,"twenty":-6.942068,"median":-4.208888,"eighty":-3.079156,"marketCap":26222481},{"date":"2022-06-10","current":-2.774931,"twenty":-6.918971,"median":-4.158782,"eighty":-3.024918,"marketCap":38692271},{"date":"2022-06-17","current":-2.679244,"twenty":-6.906139,"median":-4.117786,"eighty":-2.999671,"marketCap":37358055},{"date":"2022-06-24","current":-2.716047,"twenty":-6.880475,"median":-4.090456,"eighty":-2.939922,"marketCap":37871215},{"date":"2022-07-01","current":-2.76021,"twenty":-6.857378,"median":-4.044905,"eighty":-2.90143,"marketCap":38487007},{"date":"2022-07-08","current":-2.760137,"twenty":-6.852245,"median":-4.026684,"eighty":-2.848154,"marketCap":38485981},{"date":"2022-07-15","current":-2.668203,"twenty":-6.80605,"median":-4.008464,"eighty":-2.820986,"marketCap":37204107},{"date":"2022-07-22","current":-2.657162,"twenty":-6.72136,"median":-3.972024,"eighty":-2.802901,"marketCap":37050159},{"date":"2022-07-29","current":-2.635081,"twenty":-6.693129,"median":-3.953804,"eighty":-2.779424,"marketCap":36742263},{"date":"2022-08-05","current":-2.88534,"twenty":-6.68543,"median":-3.921918,"eighty":-2.779424,"marketCap":40231751},{"date":"2022-08-12","current":-3.956018,"twenty":-6.664899,"median":-3.844482,"eighty":-2.782292,"marketCap":49687496},{"date":"2022-08-19","current":-3.519492,"twenty":-6.618704,"median":-3.839927,"eighty":-2.785236,"marketCap":44204738},{"date":"2022-08-26","current":-3.110248,"twenty":-6.585341,"median":-3.798931,"eighty":-2.789652,"marketCap":39064652},{"date":"2022-09-02","current":-3.073871,"twenty":-6.56481,"median":-3.780666,"eighty":-2.792596,"marketCap":38607755},{"date":"2022-09-09","current":-3.965112,"twenty":-6.551978,"median":-3.772829,"eighty":-2.798485,"marketCap":49801720},{"date":"2022-09-16","current":-3.542438,"twenty":-6.531447,"median":-3.78062,"eighty":-2.805846,"marketCap":44492944},{"date":"2022-09-23","current":-2.787945,"twenty":-6.521181,"median":-3.757935,"eighty":-2.805846,"marketCap":35016525},{"date":"2022-09-30","current":-2.760341,"twenty":-6.47242,"median":-3.73516,"eighty":-2.805846,"marketCap":34669827},{"date":"2022-10-07","current":-3.128387,"twenty":-6.436491,"median":-3.71694,"eighty":-2.811734,"marketCap":39292470},{"date":"2022-10-14","current":-2.714336,"twenty":-6.41596,"median":-3.689609,"eighty":-2.811734,"marketCap":34091996},{"date":"2022-10-21","current":-2.806347,"twenty":-6.41596,"median":-3.672742,"eighty":-2.791124,"marketCap":35247657},{"date":"2022-10-28","current":-3.027174,"twenty":-6.413394,"median":-3.653169,"eighty":-2.791124,"marketCap":38021243},{"date":"2022-11-04","current":-2.723537,"twenty":-6.395429,"median":-3.644059,"eighty":-2.783423,"marketCap":34207562},{"date":"2022-11-11","current":-2.94384,"twenty":-6.362066,"median":-3.619529,"eighty":-2.778468,"marketCap":33734492},{"date":"2022-11-18","current":-3.196747,"twenty":-6.346667,"median":-3.595377,"eighty":-2.782292,"marketCap":36632644},{"date":"2022-11-25","current":-2.953956,"twenty":-6.326136,"median":-3.588921,"eighty":-2.782292,"marketCap":33850418},{"date":"2022-12-02","current":-3.338375,"twenty":-6.313304,"median":-3.534737,"eighty":-2.787945,"marketCap":38255609},{"date":"2022-12-09","current":-3.743026,"twenty":-6.300472,"median":-3.538588,"eighty":-2.789652,"marketCap":42892653},{"date":"2022-12-16","current":-3.874538,"twenty":-6.223481,"median":-3.589398,"eighty":-2.789652,"marketCap":44399692},{"date":"2022-12-23","current":-3.975701,"twenty":-6.184985,"median":-3.603063,"eighty":-2.797013,"marketCap":45558953},{"date":"2022-12-30","current":-4.026282,"twenty":-6.174719,"median":-3.62058,"eighty":-2.802902,"marketCap":46138583},{"date":"2023-01-06","current":-4.501748,"twenty":-6.172153,"median":-3.638406,"eighty":-2.805558,"marketCap":51587110},{"date":"2023-01-13","current":-4.299422,"twenty":-6.164454,"median":-3.644059,"eighty":-2.809579,"marketCap":49268588},{"date":"2023-01-20","current":-4.258957,"twenty":-6.159321,"median":-3.653169,"eighty":-2.811734,"marketCap":48804883},{"date":"2023-01-27","current":-3.884654,"twenty":-6.149055,"median":-3.672742,"eighty":-2.8141,"marketCap":44515618},{"date":"2023-02-03","current":-3.540701,"twenty":-6.118259,"median":-3.662279,"eighty":-2.817733,"marketCap":40574131},{"date":"2023-02-10","current":-3.540701,"twenty":-6.069498,"median":-3.644059,"eighty":-2.819825,"marketCap":40574131},{"date":"2023-02-17","current":-3.70246,"twenty":-6.015604,"median":-3.644059,"eighty":-2.823936,"marketCap":42427789},{"date":"2023-02-24","current":-3.287793,"twenty":-5.98994,"median":-3.641863,"eighty":-2.825677,"marketCap":37675979},{"date":"2023-03-03","current":-3.641863,"twenty":-5.979674,"median":-3.638406,"eighty":-2.827332,"marketCap":41733392},{"date":"2023-03-10","current":-3.469887,"twenty":-5.977108,"median":-3.621631,"eighty":-2.83395,"marketCap":39762648},{"date":"2023-03-17","current":-3.021341,"twenty":-5.959143,"median":-3.604508,"eighty":-2.834944,"marketCap":36536396},{"date":"2023-03-24","current":-3.406225,"twenty":-5.925781,"median":-3.592246,"eighty":-2.839484,"marketCap":41190714},{"date":"2023-03-31","current":-3.329248,"twenty":-5.907816,"median":-3.59034,"eighty":-2.843856,"marketCap":40259850},{"date":"2023-04-06","current":-3.396603,"twenty":-5.877019,"median":-3.579746,"eighty":-2.852353,"marketCap":41074356},{"date":"2023-04-14","current":-2.751922,"twenty":-5.800028,"median":-3.550817,"eighty":-2.852353,"marketCap":33278373},{"date":"2023-04-21","current":-2.97323,"twenty":-5.787196,"median":-3.550817,"eighty":-2.848143,"marketCap":35954606},{"date":"2023-04-28","current":-2.866607,"twenty":-5.735868,"median":-3.540701,"eighty":-2.852353,"marketCap":34665231},{"date":"2023-05-05","current":-2.827999,"twenty":-5.710204,"median":-3.534737,"eighty":-2.841732,"marketCap":34198359},{"date":"2023-05-12","current":-3.19477,"twenty":-5.669142,"median":-3.525038,"eighty":-2.846189,"marketCap":38633641},{"date":"2023-05-19","current":-2.850337,"twenty":-5.633213,"median":-3.510352,"eighty":-2.847975,"marketCap":35132102},{"date":"2023-05-26","current":-2.937567,"twenty":-5.611399,"median":-3.474945,"eighty":-2.849898,"marketCap":36207255},{"date":"2023-06-02","current":-2.937567,"twenty":-5.59985,"median":-3.447184,"eighty":-2.851547,"marketCap":36207255},{"date":"2023-06-09","current":-2.808114,"twenty":-5.517726,"median":-3.439538,"eighty":-2.851547,"marketCap":34611681},{"date":"2023-06-16","current":-2.738409,"twenty":-5.4433,"median":-3.429421,"eighty":-2.847807,"marketCap":33752526},{"date":"2023-06-23","current":-2.569126,"twenty":-5.402238,"median":-3.402649,"eighty":-2.838681,"marketCap":31666006},{"date":"2023-06-30","current":-2.68862,"twenty":-5.340645,"median":-3.397344,"eighty":-2.829189,"marketCap":33138844},{"date":"2023-07-07","current":-2.540461,"twenty":-5.248255,"median":-3.388974,"eighty":-2.822775,"marketCap":31312689},{"date":"2023-07-14","current":-2.40399,"twenty":-4.837634,"median":-3.364889,"eighty":-2.811734,"marketCap":29630603},{"date":"2023-07-21","current":-2.361999,"twenty":-4.609734,"median":-3.350513,"eighty":-2.798157,"marketCap":29113038},{"date":"2023-07-28","current":-1.847608,"twenty":-4.542213,"median":-3.33875,"eighty":-2.787945,"marketCap":22772865},{"date":"2023-08-04","current":-2.21503,"twenty":-4.527743,"median":-3.338375,"eighty":-2.777512,"marketCap":27301560},{"date":"2023-08-11","current":-1.900097,"twenty":-4.527743,"median":-3.329248,"eighty":-2.760341,"marketCap":23419821},{"date":"2023-08-18","current":-1.869135,"twenty":-4.501748,"median":-3.318884,"eighty":-2.76021,"marketCap":24579691},{"date":"2023-08-25","current":-2.017479,"twenty":-4.482192,"median":-3.315273,"eighty":-2.741939,"marketCap":26530461},{"date":"2023-09-01","current":-1.908693,"twenty":-4.454861,"median":-3.304204,"eighty":-2.73148,"marketCap":25099897},{"date":"2023-09-08","current":-1.75046,"twenty":-4.432997,"median":-3.297891,"eighty":-2.723392,"marketCap":23019076},{"date":"2023-09-15","current":-1.710901,"twenty":-4.39109,"median":-3.28304,"eighty":-2.713206,"marketCap":22498871},{"date":"2023-09-22","current":-1.582336,"twenty":-4.374692,"median":-3.266474,"eighty":-2.696583,"marketCap":20808204},{"date":"2023-09-29","current":-1.463661,"twenty":-4.343718,"median":-3.252322,"eighty":-2.679128,"marketCap":19247589},{"date":"2023-10-06","current":-1.542778,"twenty":-4.329142,"median":-3.235119,"eighty":-2.671147,"marketCap":20287999},{"date":"2023-10-13","current":-4.034958,"twenty":-4.32732,"median":-3.237569,"eighty":-2.671147,"marketCap":53060922},{"date":"2023-10-20","current":-4.964581,"twenty":-4.374692,"median":-3.256877,"eighty":-2.671883,"marketCap":65285742},{"date":"2023-10-27","current":-4.667893,"twenty":-4.397094,"median":-3.266474,"eighty":-2.673013,"marketCap":61384204},{"date":"2023-11-03","current":-3.758049,"twenty":-4.476726,"median":-3.28304,"eighty":-2.677757,"marketCap":49419486},{"date":"2023-11-10","current":-3.708601,"twenty":-4.449395,"median":-3.283194,"eighty":-2.678778,"marketCap":48769230},{"date":"2023-11-17","current":-3.917109,"twenty":-4.422199,"median":-3.297873,"eighty":-2.680716,"marketCap":49840076},{"date":"2023-11-24","current":-4.187628,"twenty":-4.400873,"median":-3.300382,"eighty":-2.686605,"marketCap":53282070},{"date":"2023-12-01","current":-3.808902,"twenty":-4.38198,"median":-3.312639,"eighty":-2.68862,"marketCap":48463279},{"date":"2023-12-08","current":-4.696202,"twenty":-4.38198,"median":-3.318142,"eighty":-2.693965,"marketCap":59753020},{"date":"2023-12-15","current":-3.63577,"twenty":-4.37287,"median":-3.328111,"eighty":-2.697237,"marketCap":46260402},{"date":"2023-12-22","current":-3.884647,"twenty":-4.343718,"median":-3.333812,"eighty":-2.703555,"marketCap":49427037},{"date":"2023-12-29","current":-4.295835,"twenty":-4.333177,"median":-3.338375,"eighty":-2.706495,"marketCap":54658868},{"date":"2024-01-05","current":-4.285014,"twenty":-4.33643,"median":-3.338563,"eighty":-2.708536,"marketCap":54521188},{"date":"2024-01-12","current":-5.204777,"twenty":-4.400873,"median":-3.348492,"eighty":-2.708686,"marketCap":66223969},{"date":"2024-01-19","current":-4.328297,"twenty":-4.440176,"median":-3.358415,"eighty":-2.713206,"marketCap":55071908},{"date":"2024-01-26","current":-4.317476,"twenty":-4.429326,"median":-3.377159,"eighty":-2.715705,"marketCap":54934228},{"date":"2024-02-02","current":-3.527562,"twenty":-4.406205,"median":-3.396603,"eighty":-2.721877,"marketCap":44883605},{"date":"2024-02-09","current":-3.321968,"twenty":-4.385759,"median":-3.397158,"eighty":-2.723334,"marketCap":42267689},{"date":"2024-02-16","current":-3.300327,"twenty":-4.374692,"median":-3.388974,"eighty":-2.723392,"marketCap":41992329},{"date":"2024-02-23","current":-3.386893,"twenty":-4.359111,"median":-3.386893,"eighty":-2.723485,"marketCap":43093768},{"date":"2024-03-01","current":-3.105553,"twenty":-4.341834,"median":-3.386893,"eighty":-2.727023,"marketCap":39514093},{"date":"2024-03-08","current":-3.213761,"twenty":-4.33155,"median":-3.364889,"eighty":-2.730627,"marketCap":40890891},{"date":"2024-03-15","current":-2.932421,"twenty":-4.328297,"median":-3.350513,"eighty":-2.735016,"marketCap":37311217},{"date":"2024-03-22","current":-2.226653,"twenty":-4.328297,"median":-3.33875,"eighty":-2.723485,"marketCap":32459630},{"date":"2024-03-28","current":-2.518496,"twenty":-4.327906,"median":-3.338375,"eighty":-2.718962,"marketCap":36714047},{"date":"2024-04-05","current":-2.118563,"twenty":-4.32732,"median":-3.329248,"eighty":-2.706495,"marketCap":30883919},{"date":"2024-04-12","current":-2.021282,"twenty":-4.323676,"median":-3.321968,"eighty":-2.687411,"marketCap":29465780},{"date":"2024-04-19","current":-2.302316,"twenty":-4.318209,"median":-3.318884,"eighty":-2.674142,"marketCap":33562627},{"date":"2024-04-26","current":-2.183417,"twenty":-4.318209,"median":-3.315273,"eighty":-2.664523,"marketCap":31829346},{"date":"2024-05-03","current":-2.301105,"twenty":-4.317916,"median":-3.304204,"eighty":-2.652746,"marketCap":33544976},{"date":"2024-05-10","current":-2.192562,"twenty":-4.316324,"median":-3.29791,"eighty":-2.63511,"marketCap":31962666},{"date":"2024-05-17","current":-2.129106,"twenty":-4.308527,"median":-3.285571,"eighty":-2.616729,"marketCap":34177900},{"date":"2024-05-24","current":-2.57267,"twenty":-4.299422,"median":-3.281137,"eighty":-2.577025,"marketCap":41298296},{"date":"2024-05-31","current":-2.4741,"twenty":-4.298705,"median":-3.261432,"eighty":-2.56885,"marketCap":39715986},{"date":"2024-06-07","current":-2.336102,"twenty":-4.295086,"median":-3.249273,"eighty":-2.539607,"marketCap":37500751},{"date":"2024-06-14","current":-2.447619,"twenty":-4.292088,"median":-3.24068,"eighty":-2.530313,"marketCap":39290892},{"date":"2024-06-21","current":-2.200883,"twenty":-4.290024,"median":-3.236307,"eighty":-2.524463,"marketCap":35330117},{"date":"2024-06-28","current":-2.279839,"twenty":-4.288609,"median":-3.235402,"eighty":-2.51869,"marketCap":36597565},{"date":"2024-07-05","current":-1.983756,"twenty":-4.285014,"median":-3.234651,"eighty":-2.49655,"marketCap":31844635},{"date":"2024-07-12","current":-2.269969,"twenty":-4.27919,"median":-3.233027,"eighty":-2.4741,"marketCap":36439134},{"date":"2024-07-15","current":-2.279839,"twenty":-4.277167,"median":-3.230061,"eighty":-2.4741,"marketCap":36597565},{"date":"2024-08-02","current":-2.112058,"twenty":-4.275143,"median":-3.227096,"eighty":-2.4741,"marketCap":33904238},{"date":"2024-08-09","current":-1.875192,"twenty":-4.266793,"median":-3.217086,"eighty":-2.461451,"marketCap":30101893},{"date":"2024-08-16","current":-1.980957,"twenty":-4.261607,"median":-3.210996,"eighty":-2.445765,"marketCap":33140001},{"date":"2024-08-23","current":-2.243143,"twenty":-4.254911,"median":-3.210234,"eighty":-2.400559,"marketCap":37526178},{"date":"2024-08-30","current":-2.146037,"twenty":-4.247436,"median":-3.204422,"eighty":-2.367767,"marketCap":35901668},{"date":"2024-09-06","current":-2.068352,"twenty":-4.243506,"median":-3.20294,"eighty":-2.356701,"marketCap":34602060},{"date":"2024-09-13","current":-1.951826,"twenty":-4.236218,"median":-3.197204,"eighty":-2.337786,"marketCap":32652648},{"date":"2024-09-20","current":-1.980957,"twenty":-4.232992,"median":-3.194539,"eighty":-2.284779,"marketCap":33140001},{"date":"2024-09-27","current":-1.912983,"twenty":-4.21977,"median":-3.179367,"eighty":-2.271943,"marketCap":32002845},{"date":"2024-10-04","current":-2.068352,"twenty":-4.218492,"median":-3.166398,"eighty":-2.263555,"marketCap":34602060},{"date":"2024-10-11","current":-2.0198,"twenty":-4.216571,"median":-3.159657,"eighty":-2.25327,"marketCap":33789805},{"date":"2024-10-18","current":-1.961536,"twenty":-4.206762,"median":-3.148836,"eighty":-2.238598,"marketCap":32815099},{"date":"2024-10-25","current":-1.806167,"twenty":-4.196133,"median":-3.134354,"eighty":-2.220622,"marketCap":30215884},{"date":"2024-10-31","current":-1.845009,"twenty":-4.187628,"median":-3.128387,"eighty":-2.21503,"marketCap":30865688},{"date":"2024-11-08","current":-1.815878,"twenty":-4.187628,"median":-3.123797,"eighty":-2.200883,"marketCap":30378335},{"date":"2024-11-15","current":-1.749452,"twenty":-4.187628,"median":-3.110117,"eighty":-2.183417,"marketCap":28753825},{"date":"2024-11-22","current":-1.284908,"twenty":-4.172447,"median":-3.105553,"eighty":-2.152043,"marketCap":21118628},{"date":"2024-11-29","current":-1.284729,"twenty":-4.165159,"median":-3.094733,"eighty":-2.139803,"marketCap":21115685},{"date":"2024-12-06","current":-0.793757,"twenty":-4.156049,"median":-3.088518,"eighty":-2.13527,"marketCap":13046114},{"date":"2024-12-13","current":-0.911644,"twenty":-4.148988,"median":-3.075351,"eighty":-2.117262,"marketCap":14983690},{"date":"2024-12-20","current":-0.779574,"twenty":-4.131052,"median":-3.073135,"eighty":-2.10114,"marketCap":12812997},{"date":"2024-12-27","current":-0.925005,"twenty":-4.12438,"median":-3.060459,"eighty":-2.087774,"marketCap":15203293},{"date":"2025-01-03","current":-0.863338,"twenty":-4.120736,"median":-3.05063,"eighty":-2.083924,"marketCap":14189740},{"date":"2025-01-10","current":-0.771865,"twenty":-4.114534,"median":-3.043998,"eighty":-2.068352,"marketCap":12686303},{"date":"2025-01-17","current":-0.808866,"twenty":-4.101433,"median":-3.036375,"eighty":-2.059105,"marketCap":13294435},{"date":"2025-01-24","current":-0.851107,"twenty":-4.101062,"median":-3.029808,"eighty":-2.053596,"marketCap":13988718},{"date":"2025-01-31","current":-0.780088,"twenty":-4.099566,"median":-3.026769,"eighty":-2.033103,"marketCap":12821443},{"date":"2025-02-07","current":-0.806399,"twenty":-4.090456,"median":-3.021341,"eighty":-2.0198,"marketCap":13253893},{"date":"2025-02-14","current":-0.777929,"twenty":-4.090241,"median":-3.018181,"eighty":-2.010473,"marketCap":12785969},{"date":"2025-02-21","current":-0.701154,"twenty":-4.090241,"median":-3.006671,"eighty":-1.999245,"marketCap":11524096},{"date":"2025-02-28","current":-0.705059,"twenty":-4.090241,"median":-2.992474,"eighty":-1.990668,"marketCap":11588287},{"date":"2025-03-07","current":-0.670115,"twenty":-4.087632,"median":-2.981762,"eighty":-1.986632,"marketCap":11013941},{"date":"2025-03-14","current":-0.470828,"twenty":-4.067896,"median":-2.973442,"eighty":-1.980957,"marketCap":7738476},{"date":"2025-03-21","current":-0.654878,"twenty":-4.050194,"median":-2.96744,"eighty":-1.978242,"marketCap":9235812},{"date":"2025-03-28","current":-0.662536,"twenty":-4.046959,"median":-2.954726,"eighty":-1.961536,"marketCap":9343820},{"date":"2025-04-04","current":-0.515775,"twenty":-4.046604,"median":-2.953565,"eighty":-1.951826,"marketCap":7274028},{"date":"2025-04-11","current":-0.524371,"twenty":-4.045227,"median":-2.946514,"eighty":-1.942419,"marketCap":7395262},{"date":"2025-04-17","current":-0.601894,"twenty":-4.044905,"median":-2.944364,"eighty":-1.932404,"marketCap":8488570}],"updateTime":1745304604053}}}